Artificial Intelligence is playing a pivotal role in transforming the landscape of neurodegenerative disease treatment, particularly for conditions like ALS, Alzheimer’s, and dementia. By analysing vast datasets through machine learning and deep learning, AI is enabling early detection of symptoms, often years before conventional diagnoses. In diseases like ALS, AI-powered tools are picking up subtle speech and motor abnormalities that allow for earlier intervention. Similarly, predictive models trained on patient histories are being used to forecast the onset of Alzheimer’s with high accuracy.

Beyond diagnostics, AI is also supporting the development of personalised treatment plans and identifying the most effective therapies based on a patient’s unique genetic and medical profile. In dementia care, AI-driven robots and digital assistants are improving patient quality of life by providing real-time monitoring, medication reminders, and emotional support. Moreover, advanced AI-assisted imaging tools are achieving accuracy rates above 90% in detecting early-stage Alzheimer’s.

As research advances, AI is expected to play an even greater role in the management of these conditions, with innovations like wearable monitors, AI-guided drug delivery systems, and autonomous AI agents set to redefine neurodegenerative care.